Comparison and evaluation of different effects of three alpha-Glucosidase inhibitors on lowering blood sugar and body weight in Japanese obese patients with type 2 diabetes

INTERVENTION: Miglitol 150mg/day 12weeks Voglibose 0.9mg/day 12weeks Acarbose 300mg/day 12weeks Non‐alpha‐GI‐treated 12weeks CONDITION: Type 2 Diabetes Mellitus PRIMARY OUTCOME: HbA1c,1.5‐AG,Body Weight,BMI SECONDARY OUTCOME: FPG,Serum Insulin,HOMA‐IR,Adiponectin,Leptin,; Questionnaires(digestive symptoms,appetite,drug compliance) INCLUSION CRITERIA: Japanese patients of both sexes, age 40 or older who were under the care of one of the study centers and who were obese patients with type 2 diabetes with an HbA1c of 6.4% to 8.4% (NGSP) and a body mass index (BMI) of 25 kg/m2 or above.